CLINICAL STUDIES OF THERAPIES FOR VIRUS INFECTIONS

NIH GUIDE, Volume 24, Number 22, June 16, 1995



RFP AVAILABLE:  NIH-NIAID-DMID-96-10



P.T. 34



Keywords:

  Infectious Diseases/Agents 

  Clinical Medicine, General 



National Institute of Allergy and Infectious Diseases



The Virology Branch, Division of Microbiology and Infectious Diseases

Program of the National Institute of Allergies and Infectious

Diseases (NIAID) is seeking a multicenter collaborative group to

continue ongoing clinical trials and conduct new trials to evaluate

new therapies for severe virus infections (including : herpes simplex

encephalitis, neonatal herpes, varicella zoster virus infections,

cytomegalovirus infections, parainfluenza virus infections,

respiratory syncytial virus infections, and Epstein Barr virus-

mediated diseases).  This solicitation does not include studies of

therapies for Human Immunodeficiency Virus (HIV), but does include

therapies for the above stated virus infections in HIV-infected and

other immunocompromised subjects.  The NIAID solicits proposals from

medical institutions qualified to serve as the sole Contracting Unit

or as the Central Unit of a collaborative trial.  The Contractor must

have demonstrated experience in the clinical evaluation of antivirals

and the demonstrated capacity to organize and administer a

collaborative clinical study.



This announcement is a new solicitation.  The issuance of the Request

for Proposals (RFP) will be on June 19, 1995 and proposals will be

due by COB on September 15, 1995.  It is anticipated that one

contract may be awarded as a result of this solicitation.  It is

expected that the contract will have a seven year period of

performance.



RFP No. NIH-NIAID-DMID-96-10 will be available electronically through

the NIH Gopher and via modem using the following electronic mail

addresses and instructions:



1.  To access the NIH Gopher: Point your gopher client to

GOPHER.NIH.GOV PORT 70 (you should now be in the NIH Gopher).  Select

"Grant and Research Information", then select "R&D Request for

Proposals (RFP)".



2.  To access the NIH Grant Line via modem:  Configure your terminal

emulator as:  1200 or 2400 baud, even parity, 7 data bits, 1 stop

bit, Half Duplex.  Using the procedure specified in your

communication software, dial 301-402-2221.  When you get a response

indicating that you have been connected, then type  ,GEN1  (the comma

is mandatory) and press ENTER; you will be prompted by the NIH system

for "INITIALS?".  Type  BB5  and press ENTER.  You will then be

prompted for "Account?".  Type  CCS2  and press ENTER.  Read the

12/22/94 News Flash for additional instructions.



INQUIRIES



Please note that the RFP for this procurement has been revised to

include only the Work Statement, deliverable and reporting

requirements, special requirements and mandatory qualification, if

any, the Technical Evaluation Criteria, and proposal preparation

instructions.  All information required for the submission of an

offer will be contained in the re-engineered RFP package.  Following

proposal submission and the initial review process, offerors

comprising the competitive range will be requested to provide

additional documentation (e.g., Representations and Certifications)

to the Contracting Officer.



Frank Murphy

Contract Management Branch

National Institute of Allergy and Infectious Diseases

Solar Building, Room 3C07

6003 Executive Boulevard

Rockville, MD  20852

Telephone:  (301) 496-2509



This advertisement does not commit the Government to award a

contract.



.

Return to 1995 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.